Free amino acid and dipeptide changes in the body fluids from Alzheimer’s disease subjects

Amino Acids ◽  
2006 ◽  
Vol 32 (2) ◽  
pp. 213-224 ◽  
Author(s):  
A. N. Fonteh ◽  
R. J. Harrington ◽  
A. Tsai ◽  
P. Liao ◽  
M. G. Harrington
2014 ◽  
Vol 10 ◽  
pp. P886-P887 ◽  
Author(s):  
Nobuhiro Kawai ◽  
Takahiko Muramatsu ◽  
Maiko Mori ◽  
Yasushi Noguchi ◽  
Minoru Yamakado ◽  
...  

2018 ◽  
Vol 80 (2) ◽  
pp. 235-241 ◽  
Author(s):  
Satsuki NAGAMACHI ◽  
Takuma NISHIGAWA ◽  
Mayumi TAKAKURA ◽  
Hiromi IKEDA ◽  
Momoko KODAIRA ◽  
...  

Antioxidants ◽  
2021 ◽  
Vol 10 (3) ◽  
pp. 500
Author(s):  
Juliana A. Barreto Peixoto ◽  
Gerardo Álvarez-Rivera ◽  
Rita C. Alves ◽  
Anabela S. G. Costa ◽  
Susana Machado ◽  
...  

The phenolics profile, free amino acids composition, and antioxidant potential of rosemary infusions were studied. Forty-four compounds belonging to nine different groups (hydroxybenzoic acids, hydroxycinnamic acids, flavan-3-ols, flavanones, flavones, phenolic diterpenes, hydroxybenzaldehydes, coumarins, and pyranochromanones) were identified by UHPLC-ESI-Q-TOF-MS. Of these, seven were firstly described in rosemary infusions: a rosmanol derivative, two dihydroxycoumarin hexosides, a hydroxybenzaldehyde, a dihydroxybenzoic acid hexoside, coumaric acid hexoside, and isocalolongic acid. The free amino acid profile of the beverages was also reported by the first time with seven amino acids found (asparagine, threonine, alanine, tyrosine, phenylalanine, isoleucine, and proline). Furthermore, DPPH• scavenging ability, Ferric Reducing Antioxidant Power and Oxygen Radical Absorbance Capacity, as well as total phenolics and flavonoids contents, were assessed. Overall, rosemary infusions showed to be a very good source of antioxidants. A 200 mL cup of this infusion contributes to the ingestion of ~30 mg of phenolic compounds and about 0.5–1.1 μg of free amino acids. This type of beverages may present a positive impact on the maintenance of the body antioxidant status and contribute to the prevention of oxidative stress related diseases.


2021 ◽  
Vol 11 (10) ◽  
pp. 946
Author(s):  
David Vogrinc ◽  
Katja Goričar ◽  
Tanja Kunej ◽  
Vita Dolžan

miRNAs play an important role in neurodegenerative diseases. Many miRNA-target gene interactions (MTI) have been experimentally confirmed and associated with Alzheimer’s disease (AD). miRNAs may also be contained within extracellular vesicles (EVs), mediators of cellular communication and a potential source of circulating biomarkers in body fluids. Therefore, EV-associated miRNAs (EV-miRNAs) in peripheral blood could support earlier and less invasive AD diagnostics. We aimed to prioritize EV-related miRNA with AD-related genes and to identify the most promising candidates for novel AD biomarkers. A list of unique EV-miRNAs from the literature was combined with a known set of AD risk genes and enriched for MTI. Additionally, miRNAs associated with the AD phenotype were combined with all known target genes in MTI enrichment. Expression in different sample types was analyzed to identify AD-associated miRNAs with the greatest potential as AD circulating biomarkers. Four common MTI were observed between EV-miRNAs and AD-associated miRNAs: hsa-miR-375–APH1B, hsa-miR-107–CDC42SE2, hsa-miR-375–CELF2, and hsa-miR-107–IL6. An additional 61 out of 169 unique miRNAs (36.1%) and seven out of 84 unique MTI (8.3%), observed in the body fluids of AD patients, were proposed as very strong AD-circulating biomarker candidates. Our analysis summarized several potential novel AD biomarkers, but further studies are needed to evaluate their potential in clinical practice.


Planta Medica ◽  
2008 ◽  
Vol 74 (09) ◽  
Author(s):  
EJ Cho ◽  
XL Piao ◽  
MH Jang ◽  
SY Park ◽  
SW Kwon ◽  
...  

Planta Medica ◽  
2008 ◽  
Vol 74 (09) ◽  
Author(s):  
BM Silva ◽  
AP Oliveira ◽  
DM Pereira ◽  
C Sousa ◽  
RM Seabra ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document